These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21443679)

  • 1. Food patterns, inflammation markers and incidence of cardiovascular disease: the Malmö Diet and Cancer study.
    Hlebowicz J; Persson M; Gullberg B; Sonestedt E; Wallström P; Drake I; Nilsson J; Hedblad B; Wirfält E
    J Intern Med; 2011 Oct; 270(4):365-76. PubMed ID: 21443679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M; Engström G; Björkbacka H; Hedblad B
    Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
    Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
    Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort.
    Persson M; Nilsson JA; Nelson JJ; Hedblad B; Berglund G
    Atherosclerosis; 2007 Feb; 190(2):388-96. PubMed ID: 16530769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension.
    Li C; Engström G; Hedblad B; Janzon L
    J Hypertens; 2006 Aug; 24(8):1523-9. PubMed ID: 16877954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study.
    Panagiotakos DB; Pitsavos C; Chrysohoou C; Skoumas I; Stefanadis C;
    Vasc Med; 2008; 13(2):113-21. PubMed ID: 18593800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.
    Furberg CD; Nelson JJ; Solomon C; Cushman M; Jenny NS; Psaty BM
    J Am Geriatr Soc; 2008 May; 56(5):792-9. PubMed ID: 18363676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study.
    Engström G; Hedblad B; Stavenow L; Jonsson S; Lind P; Janzon L; Lindgärde F
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1498-502. PubMed ID: 15178569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women.
    Tzotzas T; Filippatos TD; Triantos A; Bruckert E; Tselepis AD; Kiortsis DN
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):477-82. PubMed ID: 17928209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cardiovascular disease and diet of urban and rural dwellers in northern Nigeria.
    Glew RH; Conn CA; Vanderjagt TA; Calvin CD; Obadofin MO; Crossey M; Vanderjagt DJ
    J Health Popul Nutr; 2004 Dec; 22(4):357-69. PubMed ID: 15663169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular event risk in relation to dietary fat intake in middle-aged individuals: data from The Malmö Diet and Cancer Study.
    Leosdottir M; Nilsson PM; Nilsson JA; Berglund G
    Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):701-6. PubMed ID: 17925631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease.
    Salas-Salvadó J; Garcia-Arellano A; Estruch R; Marquez-Sandoval F; Corella D; Fiol M; Gómez-Gracia E; Viñoles E; Arós F; Herrera C; Lahoz C; Lapetra J; Perona JS; Muñoz-Aguado D; Martínez-González MA; Ros E;
    Eur J Clin Nutr; 2008 May; 62(5):651-9. PubMed ID: 17440519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Circulation; 2007 Apr; 115(16):2119-27. PubMed ID: 17404162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.